| Prognostic significance of Dicer expression in ovarian cancer—link to global microRNA changes and oestrogen receptor expression A Faggad, J Budczies, O Tchernitsa, S Darb‐Esfahani, J Sehouli, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010 | 99 | 2010 |
| Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro S Darb-Esfahani, A Faggad, A Noske, W Weichert, AC Buckendahl, ... Journal of cancer research and clinical oncology 135, 933-941, 2009 | 96 | 2009 |
| Down‐regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer A Faggad, A Kasajima, W Weichert, A Stenzinger, NE Elwali, M Dietel, ... Histopathology 61 (4), 552-561, 2012 | 55 | 2012 |
| Topoisomerase IIα mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis A Faggad, S Darb-Esfahani, R Wirtz, B Sinn, J Sehouli, D Könsgen, ... Modern pathology 22 (4), 579-588, 2009 | 53 | 2009 |
| IMP3 expression in human ovarian cancer is associated with improved survival A Noske, A Faggad, R Wirtz, S Darb-Esfahani, J Sehouli, B Sinn, ... International journal of gynecological pathology 28 (3), 203-210, 2009 | 52 | 2009 |
| Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue S Darb-Esfahani, RM Wirtz, BV Sinn, J Budczies, A Noske, W Weichert, ... Endocrine-related cancer 16 (4), 1229-1239, 2009 | 44 | 2009 |
| Expression of multidrug resistance‐associated protein 1 in invasive ovarian carcinoma: implication for prognosis A Faggad, S Darb‐Esfahani, R Wirtz, B Sinn, J Sehouli, D Könsgen, ... Histopathology 54 (6), 657-666, 2009 | 42 | 2009 |
| C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese AC Dongway, AS Faggad, HY Zaki, BE Abdalla Diabetes, metabolic syndrome and obesity: targets and therapy, 427-435, 2015 | 40 | 2015 |
| Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue BV Sinn, S Darb-Esfahani, RM Wirtz, A Faggad, W Weichert, ... Virchows Archiv 455, 461-467, 2009 | 29 | 2009 |
| Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal S Eljack, S David, A Faggad, I Chourpa, E Allard-Vannier International Journal of Pharmaceutics: X 4, 100126, 2022 | 16 | 2022 |
| Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015) Jeddah, Kingdom of Saudi Arabia. 30 November-3 December 2015 JW Shay, N Homma, R Zhou, MI Naseer, AG Chaudhary, M Al-Qahtani, ... BMC genomics 17, 1-78, 2016 | 15 | 2016 |
| Survival outcomes of breast cancer in sudanese women: a hospital-based study HF Muddather, MMA Elhassan, A Faggad JCO Global Oncology 7 (1), 324-332, 2021 | 10 | 2021 |
| Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for efficient anti-cancer activity in HER2+ breast Cancer cells S Eljack, E Allard-Vannier, Y Misericordia, K Hervé-Aubert, N Aubrey, ... Pharmaceutics 14 (11), 2537, 2022 | 6 | 2022 |
| Characteristics of breast cancer at first presentation in Sudanese patients attending the national cancer institute–university of gezira (NCI–UG) MA Eltayeb, A Faggad, OS Abbadi, MMA Elhassan Archives of Breast Cancer, 104-110, 2020 | 6 | 2020 |
| Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience MMA Elhassan, MDA Gismalla, SAH Mohamed, A Faggad Thyroid Research 16 (1), 35, 2023 | 3 | 2023 |
| Increased Fasting Plasma Glucose and Breast Cancer Risk in Sudanese Women: Association with Premenopausal Status and High Body Mass Index HMA Osman, AS Faggad Asian Pacific Journal of Cancer Biology 7 (4), 289-295, 2022 | 2 | 2022 |
| Lipid profiles of Sudanese cancer patients AM Abas, HY Zaki, A Faggad, AM Alhaj, BE Abdalla Sudan Med J 50 (1), 2014 | 2 | 2014 |
| Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment S Eljack, S David, I Chourpa, A Faggad, E Allard-Vannier Pharmaceuticals 15 (12), 1452, 2022 | 1 | 2022 |
| Relapse-free survival in Sudanese women with non-metastatic breast cancer HF Muddather, A Faggad, MMA Elhassan Global Epidemiology 4, 100082, 2022 | | 2022 |
| Association of ESR1 polymorphisms (rs3020314 and rs1514348) with breast cancer in Sudanese women. A pilot study AT Gebreslasie, A Faggad, HY Zaki, BE Abdalla Gene Reports 15, 100396, 2019 | | 2019 |
Carsten DenkertProfessor of Pathology, Philipps-University Marburg, GermanyVerified email at uni-marburg.de
